Sinopep-Allsino Bio Pharmaceutical Co., Ltd.SSE: 688076

Announcement on Implementation of Dividend Distribution for 2024

Jun 5, 2025 · Issued by Sinopep-Allsino Bio Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jun 5, 2025

On 6ix: 6ix.com/news/announcement-on-implementation-of-dividend-distribution-for-2024-971

Announcement on Implementation of Dividend Distribution for 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Sinopep-Allsino Bio Pharmaceutical Co., Ltd. on 6ix

Earlier from Sinopep-Allsino Bio Pharmaceutical

Announcement on Voluntary Disclosure of Obtaining Drug Registration Certificate for Fluvoxamine Maleate TabletsMay 28, 2025
Announcement on Resolution of the 2024 Annual General MeetingMay 24, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance BriefingMay 16, 2025
Announcement on Redemption Results of "Sinopep-Allsino Convertible Bonds" and Share ChangesApr 26, 2025
The Last Indicative Announcement on the Implementation of Redemption and Delisting of "Sinopep-Allsino Convertible Bonds"Apr 24, 2025

Later from Sinopep-Allsino Bio Pharmaceutical

Announcement on Voluntary Disclosure of Signing Strategic Cooperation AgreementJun 7, 2025
Announcement on Adjusting Matters Related to the 2023 Restricted Stock Incentive PlanJun 27, 2025
Announcement on Voluntary Disclosure of Earnings Preannouncement for 2025 Interim ResultsJul 4, 2025
Announcement on Implementation of Other Risk Warnings and Trading SuspensionJul 19, 2025
Announcement on the Voluntary Disclosure of Receiving Drug Registration Certificates for Sequiretic Acetate Injection and Agomelatine TabletsAug 1, 2025

All Sinopep-Allsino Bio Pharmaceutical news releases

Follow Sinopep-Allsino Bio Pharmaceutical into a list and get an email when it puts out news.

Follow Sinopep-Allsino Bio Pharmaceutical